Advanced and Targeted Drug Delivery Market to 2021 - Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment - Research and Markets
DUBLIN, July 26, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021" report to their offering.
Advanced and Targeted Drug Delivery Market to grow at a 10.4% CAGR to $319 billion by 2021 from $168 billion in 2016
The advanced and targeted drug delivery market is segmented and analysed through to 2021 with corresponding CAGR breakdown by:
- Technology (Nanoparticles, Polymers (micelles, dendrimers etc), Monoclonal antibodies, Gold nanoparticles-based drug delivery and imaging, Drug eluting stents)
- Geography (Global, USA, Europe, RoW)
- Therapeutic Area (Pulmonary, Ocular drug delivery, Ocular nano-based drug delivery implants, Drug Eluting Stents,
- Sub-Market Analysis (details below)
The monoclonal antibody market is further broken down and presented as the top selling mAbs by company, class and revenue through to 2021 with corresponding CAGR values. Specific figures are given in relation to Humira, Remicade, Avastin, Rituxan, Soliris, Herceptin, Kadcyla, Perjeta, Lucentis, Xgeva/Prolia, Stelara and Tysarbi.
The global market for nano-based targeted drug delivery is presented by the following sub-markets liposomes, polymers (micelles, dendrimers etc) and gold nano-particles through to 2021 with corresponding CAGR figures.
The global pulmonary drug delivery market is analysed and presented as metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulizers through 2021 with corresponding CAGR data. This market is also divided into the following geographical regions USA, Europe, RoW, Global through 2021 with corresponding CAGR analysis.
Key Questions Answered in this Report:
- What are the maximum drug release times reported for various nano-based drug carriers?
- What regulatory agencies are approving specific nanomedicines?
- How many liposome-based drugs are available in the market?
- How many stealth liposomes have been granted market approval?
- How many PEGylated liposomes are used for targeted drug delivery?
- Who are the leading players in liposome-based drug formulation?
- What are stimuli-responsive polymers?
- Who are the market leaders in polymer-based drugs?
- What dendrimer-based drugs are the commercially available for targeted delivery?
- What are the applications of inorganic nanoparticles in targeted drug deliver?
- Which companies are focusing on inorganic nanoparticles for targeted drug delivery?
- What are the applications of magnetic nanoparticles in drug delivery, diagnostic and imaging?
- What is the global market value of nanomedicines?
- What is the global market for nanomedicines by therapeutic areas?
- What is the global market for monoclonal antibodies by geography?
- What are the best-selling mAbs?
- What is the global market for major targeted delivery systems?
Key Topics Covered:
1.0 Introduction
2.0 Targeted Drug Delivery: An Overview
3.0 Targeted Drug Delivery and Nanomedicines: An Overview
4.0 Lipid-Based Targeted Drug Delivery Nanosystems
5.0 Polymer-Based Carriers for Targeted Drug Delivery
6.0 Polymeric Micelle/Co-Polymers for Targeted Drug Delivery
7.0 Dendrimer-Based Targeted Drug Delivery
8.0 Inorganic Nanoparticles for Targeted Drug Delivery
9.0 Cell-Based Systems for Targeted Delivery
10.0 Nucleic Acid/Peptide as Drug Carriers
11.0 Targeted Therapies by Indication: An Overview
12.0 Other Targeted Drug Delivery Technologies
13.0 Market Analysis to 2021
14.0 Selected Company Profiles
Companies Mentioned
- 3M Company
- Abbott Laboratories
- Ablynx NV
- Aciont Inc.
- Acrux
- Agilis Biotherapeutics LLC
- Aileron Therapeutics Inc.
- Alchemia Oncology Pty Ltd.
- Alkermes Pharma Ireland Ltd.
- Allergan Inc.
- Alnylam Pharmaceuticals
- AmpliPhi Biosciences
- Andros Pharmaceuticals Co., Ltd.
- Angiochem Inc.
- Antares Pharma Inc.
- Aposense Ltd.
- Applied Genetic Technologies Corp. (AGTC)
- Aptagen LLC
- Aradigm Corp.
- ArisGen SA
- Armagen Technologies Inc.
- Arrowhead Research Corp.
- Artificial Cell Technologies Inc.
- AsclepiX Therapeutics LLC
- Asklepios BioPharmaceutical Inc.
- Astellas Pharma Inc.
- Audentes Therapeutics Inc.
- Avalanche Biotechnologies Inc.
- Avita Medical Ltd.
- Azaya Therapeutics Inc.
- Bachem Americas Inc.
- Bayer Pharma AG
- BBB Therapeutics BV
- Bespak Europe Ltd.
- Bicycle Therapeutics Ltd.
- BigDNA Ltd.
- BIND Therapeutics Inc.
- BioDelivery Sciences International Inc.
- Bioject Medical Technologies Inc.
- BioZone Laboratories Inc.
- Camurus AB
- Celsion Corp.
- CeramiSphere Pty Ltd.
- Cerulean Pharma Inc.
- Chrysalis BioTherapeutics Inc.
- Copernicus Therapeutics Inc.
- Cornerstone Pharmaceuticals Inc.
- CureVac AG
- CytImmune Sciences Inc.
- DepoMed Inc.
- Dicerna Pharmaceuticals
- Dimension Therapeutics Inc.
- Dipexium Pharmaceuticals Inc.
- Discovery Laboratories Inc.
- DURECT
- EnGeneIC Ltd
- Ensysce Biosciences Inc.
- EryDel SpA
- EryTech Pharma
- Esperance Pharmaceuticals Inc.
- Exicure Inc.
- FIT Biotech Oy
- Flamel Technologies S.A.
- Generex Biotechnology Corp.
- Genetic Immunity Inc.
- Genus Pharmaceuticals Ltd.
- GenVec Inc.
- GlaxoSmithKline LLC
- Glide Pharmaceutical Technologies Ltd.
- Heron Therapeutics Inc.
- Hoffmann-LaRoche Inc.
- ICB International Inc.
- iCeutica Inc.
- ImmusanT Inc.
- InDex Pharmaceuticals AB
- Immune Design
- Immunocore Ltd.
- Inovio Pharmaceuticals
- Insite Vision Inc.
- Insmed Inc.
- Intezyne Technologies Inc.
- Keystone Nano Inc.
- Kowa Pharmaceuticals America Inc.
- LipimetiX Inc.
- LiPlasome Pharma ApS
- Lipocine Inc.
- Lipotek Pty Ltd.
- Living Cell Technologies Ltd.
- MagForce AG
- Mankind Pharma Ltd.
- Mersana Therapeutics Inc.
- Micochips Biotech Inc.
- Milo Biotechnology LLC
- miRagen Therapeutics Inc.
- Mirna Therapeutics Inc.
- Miros Polymers Inc.
- Moderna Therapeutics Inc.
- MultiVir Inc.
- Mystic Pharmaceuticals Inc.
- Nanobiotix
- Nanocarrier Co., Ltd.
- Nanocopoeia Inc.
- NanoMedical Systems Inc.
- NanoOncology Inc. (PeptiMed Inc.)
- Nanospectra Biosciences Inc.
- Nano Precision Medical Inc.
- Nanotherapeutics Inc.
- nanoTherics Ltd
- Magnefect System
- NanoVector Inc.
- NanoViricides Inc.
- Nektar Therapeutics
- Neos Therapeutics Inc.
- NeXstar Pharmaceuticals Inc.
- NightstaRx Ltd.
- NOD Pharmaceuticals Inc.
- Nordic Nanovector ASA
- Novagali Pharma S.A.
- Novasorb Technology
- Novartis Pharmaceuticals Corp.
- Ocular Therapeutix Inc.
- Oncolytics Biotech Inc.
- Oxford Biomedica plc
- PDS Biotechnology Corp.
- PharmaIN Corp.
- PhaseRx Inc.
- Phico Therapeutics Ltd.
- PolyActiva Pty Ltd.
- PolyTherics Ltd.
- Presage Biosciences Inc.
- pSivida Corp.
- Pulmatrix Inc.
- Quark Pharmaceuticals Inc.
- Ra Pharmaceuticals Inc.
- RaNA Therapeutics Inc.
- RegeneRx Biopharmaceuticals Inc.
- Regenxbio Inc.
- Renova Therapeutics Inc.
- Replicor Inc.
- RetroSense Therapeutics LLC
- Rexahn Pharmaceuticals Inc.
- RJS Biologics LLC
- Roche Holding AG
- Sarfez Pharmaceuticals Inc.
- Savara Inc.
- Scintipharma Inc.
- Sequus Pharmaceuticals Inc.
- Serina Therapeutics Inc.
- Serpin Pharma LLC
- Silence Therapeutics PLC
- Silenseed Ltd.
- Sylentis SA
- SoluBest Ltd.
- Spark Therapeutics
- Spheringenics Inc.
- Suda Ltd.
- Supratek Pharma Inc.
- Taiwan Liposome Co. Ltd.
- TheraSource LLC
- Transgene SA
- Valeant Pharmaceuticals International Inc.
- Efudex
- Vect-Horus S.A.S.
- Vectura Group plc
- Vical Inc.
- Voyager Therapeutics Inc.
- WAVE Life Sciences Pvt. Ltd.
- Xel Pharmaceuticals
- Xenetic Biosciences
- Xigen SA
- Zealand Pharma AS
- Zozano Pharma Corp
For more information visit http://www.researchandmarkets.com/research/m3gm88/advanced_and
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article